The main purpose of this study was to improve mood and behavior disorders in RTT patients
with venlafaxine (SNRI), and compare the results with citalopram (SSRIs) during 6 - 8 weeks, to determine which drug offered greater efficacy and fewer side effects, as well as to compare them to risperidone, and to correlate cortisol levels in saliva with stress and drug response.
Ninety six adult outpatients with DSM - IV obsessive - compulsive disorder (OCD) who had responded to three months of medication (⩾ 25 % reduction in score on Yale - Brown Obsessive Compulsive Scale (Y - BOCS)-RRB-
with venlafaxine (300 mg / day) or paroxetine (60 mg / day).
Behavioral profile in comparison
with venlafaxine, reboxetine, citalopram, and clomipramine.
Not exact matches
Outpatients (N = 421) in primary care or psychiatry settings meeting DSM - IV criteria for GAD were randomly assigned to 6 weeks of double - blind treatment
with pregabalin 400 or 600 mg / day,
venlafaxine 75 mg / day, or placebo.
Brain blood flow changes in depressed patients treated
with interpersonal psychotherapy or
venlafaxine hydrochloride: Preliminary findings.
OpenUrlCrossRefPubMedWeb of Science Q Does pregabalin or
venlafaxine treatment reduce symptoms of generalised anxiety disorder compared
with placebo?
Major depressive disorder: similar remission rates
with bupropion, sertraline, or
venlafaxine following treatment switch from citalopram